Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010;93(4):1234–43.
Article CAS PubMed Google Scholar
Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta. 1994;15(8):819–35.
Article CAS PubMed Google Scholar
Doni A, Mantovani G, Porta C, et al. Cell specific regulation of PTX3 by glucocorticoid hormones in hematopoietic and nonhematopoietic cells. J Biol Chem. 2008;283(44):29983–92.
Article CAS PubMed PubMed Central Google Scholar
Choi BC, Polgar K, Xiao L, Hill JA. Progesterone inhibits in-vitro embryotoxic Thl cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod. 2000;15(1):46–59.
Article CAS PubMed Google Scholar
Raghupathy R, Al-Mutawa E, Al-Azemi M, et al. Progesterone-induced blocking (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery. J Reprod Immunol. 2009;80(1):91–9.
Article CAS PubMed Google Scholar
Daher S, de Arruda Geraldes-Denardi K, Blotta MH, et al. Cytokines in recurrent pregnancy loss. J Reprod Immunol. 2004;62:151–7.
Article CAS PubMed Google Scholar
Pietrowski D, Bettendorf H, Keck C, et al. Lack of association of TNFalpha gene polymorphisms and recurrent pregnancy loss in Caucasian women. J Reprod Immunol. 2004;61(1):51–8.
Article CAS PubMed Google Scholar
Kumar A, Begum N, Prasad S, Aggarwal S, Sharma S. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertil Steril. 2014;102(5):1357-1363.e3.
Article CAS PubMed Google Scholar
Ismail AM, Agban MN, Hasanein AS, Rayan AA, Abbas AM. Role of Th-1 cell cytokines, leukemia inhibitory factor and hoxA genes in women with recurrent pregnancy loss. Middle East Fertil Society J. 2017;22(4):300–4.
Talukdar A, Rai R, Sharma KA, Rao DN, Sharma A. Peripheral Gamma Delta T cells secrete inflammatory cytokines in women with idiopathic recurrent pregnancy loss. Cytokine. 2018;102:117–22.
Article CAS PubMed Google Scholar
Ali S, Mazid S, Ali MN, Taing S, Rehman MU, Arafah A. Cytokine imbalance at materno-embryonic interface as a potential immune mechanism for recurrent pregnancy loss. Int Immunopharmacol. 2021;90: 107118.
Article CAS PubMed Google Scholar
Ibrahim MI, Harb HM, Ellaithy MI, Elkabarity RH, Abdelgwad MH. First trimester assessment of pentraxin-3 levels in women with primary unexplained recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2012;165(1):37–41.
Article CAS PubMed Google Scholar
Zeybek S, Tepeli E, Cetin GO, et al. Increased expression of Pentraxin 3 in placental tissue from patients with unexplained recurrent pregnancy loss. Balkan J Med Genet. 2019;22(1):21–8.
Article CAS PubMed PubMed Central Google Scholar
Larsson A, Palm M, Helmersson J, Axelsson O. Pentraxin 3 values during normal pregnancy. Inflammation. 2011;34(5):448–51.
Article CAS PubMed Google Scholar
Hussain GA, Azizieh F, Makhseed M, Raghupathy R. Effects of progesterone dydrogesterone and estrogen on the production of TH1/TH2/Th17 cytokines by lymphocytes from women with recurrent spontaneous miscarriage. J Reprod Immumol. 2020;140: 103132.
Coomarasamy A, Williams H, Truchanowicz E, et al. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med. 2015;373(22):2141–8.
Article CAS PubMed Google Scholar
Makhseed M, Raghupathy R, Azizieh F, Farhat R, Hassan N, Bandar A. Circulating cytokines and CD30 in normal human pregnancy and recurrent spontaneous abortions. Hum Reprod. 2000;15(9):2011–7.
Article CAS PubMed Google Scholar
Russu M, Stanculescu R, Paun M, Marin JA. Neonatal outcomes after preconceptional vaginal micronized progesterone administration in recurrent pregnancy loss: five years prospective study. Donald School J Ultras Obstetr Gynecol. 2014;8(2):128–33.
留言 (0)